These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1550008)

  • 1. Heart rate variations during isoproterenol infusion in congestive heart failure: relationships to cardiac mortality.
    Brembilla-Perrot B
    Am Heart J; 1992 Apr; 123(4 Pt 1):989-92. PubMed ID: 1550008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.
    Cygankiewicz I; Zareba W; Vazquez R; Vallverdu M; Gonzalez-Juanatey JR; Valdes M; Almendral J; Cinca J; Caminal P; de Luna AB;
    Heart Rhythm; 2008 Aug; 5(8):1095-1102. PubMed ID: 18675217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure.
    Fei L; Keeling PJ; Gill JS; Bashir Y; Statters DJ; Poloniecki J; McKenna WJ; Camm AJ
    Br Heart J; 1994 Apr; 71(4):322-8. PubMed ID: 8198881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.
    Stellbrink C; Auricchio A; Diem B; Breithardt OA; Kloss M; Schöndube FA; Klein H; Messmer BJ; Hanrath P
    Am J Cardiol; 1999 Mar; 83(5B):143D-150D. PubMed ID: 10089857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in patients with heart failure treated with cardiac resynchronisation therapy. A long-term multi-centre follow-up study.
    Sterliński M; Maciag A; Kowalski O; Gościńska-Bis K; Pytkowski M; Kowalik I; Lewicka-Nowak E; Mitkowski P; Kaźmierczak J; Kalarus Z; Kargul W; Lubiński A; Cieśliński A; Kornacewicz-Jach Z; Szwed H; Sadowski Z
    Kardiol Pol; 2007 Nov; 65(11):1287-93; discussion 1294-5. PubMed ID: 18058579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing.
    Miyoshi F; Kobayashi Y; Itou H; Onuki T; Matsuyama T; Watanabe N; Liu C; Kawamura M; Asano T; Miyata A; Nakagawa H; Tanno K; Baba T; Katagiri T
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1182-8. PubMed ID: 16359284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.
    Grassi G; Seravalle G; Cattaneo BM; Lanfranchi A; Vailati S; Giannattasio C; Del Bo A; Sala C; Bolla GB; Pozzi M
    Circulation; 1995 Dec; 92(11):3206-11. PubMed ID: 7586305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality.
    Anastasiou-Nana MI; Nanas JN; Karagounis LA; Tsagalou EP; Alexopoulos GE; Toumanidis S; Gerali S; Stamatelopoulos SF; Moulopoulos SD
    Am J Cardiol; 2000 May; 85(10):1212-7. PubMed ID: 10802003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.
    Doval HC; Nul DR; Grancelli HO; Varini SD; Soifer S; Corrado G; Dubner S; Scapin O; Perrone SV
    Circulation; 1996 Dec; 94(12):3198-203. PubMed ID: 8989129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure].
    Wang DM; Han YL; Zang HY; Zhou WW; Jing QM; Wang ZL; Wang SL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):717-9. PubMed ID: 16188059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
    He Z; Sun C; Xu Y; Cheng D
    Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.